Year of investment: 2007
PharmaCell is world leader in cell-culturing services using its GMP-certified manufacturing facilities in Maastricht and Geleen. Its customers include the world leaders in commercial cell therapy products. Pharmacell has access to an extensive network which gives it the capability to provide support and/or partnership to R&D companies to bring new products from the lab into the clinic.
Year of investment: 2006
Oxford Performance Materials supplies its versatile OXPEKK® polymers to space and defense, medical, semiconductor, and industrial markets worldwide. The company was sold to Arkema in early 2009.
Year of investment: 2006
Polyscope Polymers is a supplier of SMA copolymers for the automotive, paper and construction industries. Its engineering plastics compounds are sold primarily to the automotive industry for e.g. instrument panels and roof frames. Its low molecular grades, low and high MA content grades, liquid forms and imidized products find applications in many specialty markets. The company is based at the Chemelot site where it also has its production assets.
Year of investment: 2004
In 2009 the company was part of a transaction involving an MBI and which provided a partial exit for shareholders.
The assets were transferred to Fortimedix Holding BV.